EGFR and neoplasm: DFCI81 xenograft-bearing mice showed no tumor growth after 100 days of drug cessation after treatment with a single-agent MET inhibitor, whereas in the DFCI161 and DFCI307 models, tumor outgrowth after drug withdrawal was similar in mice treated with a MET inhibitor alone or in combination with an EGFR inhibitor (fig.